DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge is a research paper published in mBio (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: R01AI134862
HHS | National Institutes of Health
Grant: R56AI150965
HHS | National Institutes of Health
Grant: R01AI1506701A1
HHS | National Institutes of Health
Grant: 3U01CA260541-02S1
SARS-CoV-2 correlates of protection in a Latino-origin population
NIH HHS
Grant: P40 OD012217
NIAID NIH HHS
Grant: F31 AI152460
NCI NIH HHS
Grant: U01 CA260541
NINDS NIH HHS
Grant: F31 NS087866
National Institutes of Health
Grant: 1R56AI150965-01A1
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy
National Institutes of Health
Grant: 5R01AI134862-04
Mechanisms of DDO Adjuvancy
Fields of Study
MeSH Terms
Keywords